One in 10 people may have resistance to GLP-1 diabetes drugs

Stanford Medicine·Apr 10

This story is reported by Stanford Medicine. Read what other outlets are saying below, then open the original report for full details.

Full coverage

1

Scientists discover why ozempic may not work for some people

ScienceDaily·Jun 5

2

Genetic predictors of GLP1 receptor agonist weight loss and side effects

Nature·Apr 8

3

GLP-1 Resistance: Causes and Implications for Diabetes Treatment

MedCentral·Apr 30

4

Why Some Patients Do Not Respond to GLP-1 Therapies

Pharmacy Times – Pharmacy Practice News and Expert Insights·Jun 2

5

Stanford Medicine experts go deep on GLP-1s

Stanford Report·Jun 29

6

Ozempic, Wegovy: Why GLP-1 Drugs Don't Work for Everyone

Healthline·Apr 14

7

Why weight-loss drugs don’t work for some people

The Conversation·Jun 17

8

Scientists May Now Know Why GLP-1s Don't Work For 10% of People

ScienceAlert·Apr 15